CID 11809239

Details

Top
Internal ID 348cfb7c-e451-44e4-a67a-c5ffae8094fd
Taxonomy Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Glycosyl compounds > O-glycosyl compounds
IUPAC Name 4-hydroxy-4-[2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]cyclohexa-2,5-dien-1-one
SMILES (Canonical) C1=CC(C=CC1=O)(CCOC2C(C(C(C(O2)CO)O)O)O)O
SMILES (Isomeric) C1=CC(C=CC1=O)(CCO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O
InChI InChI=1S/C14H20O8/c15-7-9-10(17)11(18)12(19)13(22-9)21-6-5-14(20)3-1-8(16)2-4-14/h1-4,9-13,15,17-20H,5-7H2/t9-,10-,11+,12-,13-/m1/s1
InChI Key VTVARPTUBCBNJX-UJPOAAIJSA-N
Popularity 4 references in papers

Physical and Chemical Properties

Top
Molecular Formula C14H20O8
Molecular Weight 316.30 g/mol
Exact Mass 316.11581759 g/mol
Topological Polar Surface Area (TPSA) 137.00 Ų
XlogP -2.10
Atomic LogP (AlogP) -2.38
H-Bond Acceptor 8
H-Bond Donor 5
Rotatable Bonds 5

Synonyms

Top
40661-45-8
4-[2-(beta-D-Glucopyranosyloxy)ethyl]-4-hydroxy-2,5-cyclohexadien-1-one
HY-N7962
AKOS040761529
CS-0138891
4-hydroxy-4-[2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]cyclohexa-2,5-dien-1-one

2D Structure

Top
2D Structure of CID 11809239

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.8425 84.25%
Caco-2 - 0.7662 76.62%
Blood Brain Barrier + 0.5250 52.50%
Human oral bioavailability - 0.7143 71.43%
Subcellular localzation Mitochondria 0.8254 82.54%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9215 92.15%
OATP1B3 inhibitior + 0.9440 94.40%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior - 0.9309 93.09%
P-glycoprotein inhibitior - 0.9093 90.93%
P-glycoprotein substrate - 0.9548 95.48%
CYP3A4 substrate + 0.5357 53.57%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8620 86.20%
CYP3A4 inhibition - 0.9250 92.50%
CYP2C9 inhibition - 0.8838 88.38%
CYP2C19 inhibition - 0.8862 88.62%
CYP2D6 inhibition - 0.9377 93.77%
CYP1A2 inhibition - 0.9505 95.05%
CYP2C8 inhibition - 0.8522 85.22%
CYP inhibitory promiscuity - 0.9378 93.78%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6889 68.89%
Eye corrosion - 0.9883 98.83%
Eye irritation - 0.9102 91.02%
Skin irritation - 0.8204 82.04%
Skin corrosion - 0.9418 94.18%
Ames mutagenesis - 0.6000 60.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7935 79.35%
Micronuclear - 0.8441 84.41%
Hepatotoxicity - 0.6770 67.70%
skin sensitisation - 0.8704 87.04%
Respiratory toxicity + 0.5556 55.56%
Reproductive toxicity - 0.5333 53.33%
Mitochondrial toxicity - 0.5125 51.25%
Nephrotoxicity + 0.4838 48.38%
Acute Oral Toxicity (c) III 0.5134 51.34%
Estrogen receptor binding - 0.6466 64.66%
Androgen receptor binding - 0.5911 59.11%
Thyroid receptor binding + 0.5628 56.28%
Glucocorticoid receptor binding + 0.6277 62.77%
Aromatase binding - 0.5412 54.12%
PPAR gamma - 0.5468 54.68%
Honey bee toxicity - 0.8498 84.98%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.7350 73.50%
Fish aquatic toxicity - 0.7990 79.90%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.55% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 88.78% 96.09%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 86.99% 94.00%
CHEMBL3401 O75469 Pregnane X receptor 84.02% 94.73%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 81.87% 85.14%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 80.17% 96.00%

Cross-Links

Top
PubChem 11809239
NPASS NPC13748
LOTUS LTS0118163
wikiData Q104375849